Literature DB >> 20658291

The spectrum of thyroid disorders in systemic lupus erythematosus.

Kundan Kumar1, Alakes Kumar Kole, Partha Sarathi Karmakar, Alakendu Ghosh.   

Abstract

To study the spectrum of thyroid disorders in systemic lupus erythematosus (SLE). Hundred SLE patients as per American Rheumatology Association(ARA) classification criteria underwent clinical examination, including assessment of disease activity (SLEDAI) and laboratory evaluation for serum triiodothyronine (T3),free thyroxine (FT4), thyroid stimulating hormone (TSH), antithyroperoxidase (TPO) antibody and antithyroglobulin (TG) antibody. Hundred age- and sex-matched apparently healthy individuals served as control. Thirty-six (36%) lupus patients had thyroid dysfunction when compared to 8 (8%) of controls and all of them were women. Primary hypothyroidism was the commonest dysfunction in 14 (14%), while subclinical hypothyroidism and subclinical hyperthyroidism was seen in 12 (12%) and 2 (2%), respectively. Eight (8%) had isolated low T3 consistent with sick euthyroid syndrome. Eighteen (50%) of thyroid dysfunction were autoimmune in nature (autoantibody positive) and rest 18 (50%) were non-autoimmune. Euthyroid state with the elevation of antibodies alone was seen in 12 (12%) of the lupus patients. In contrast, only 5 (5%) of controls had primary hypothyroidism and 3 (3%) had subclinical hypothyroidism, while none had hyperthyroidism. SLEDAI score and disease duration were compared between lupus patients with thyroid dysfunction to those with normal thyroid function. A statistically significant association was found between SLEDAI and thyroid dysfunction of sick euthyroid type.SLE disease duration had no statistically significant association with thyroid dysfunction. Prevalence of thyroid autoantibodies in lupus patients was 30% when compared to 10% of controls. Ninety-six (96%) of the SLE patients were ANA positive, while 4 (4%) of them were ANA negative but were anti-Sm antibody positive. There were no suggestions of any other autoimmune endocrine diseases like diabetes or Addison's disease (clinically and on baseline investigations) in our lupus cohort and hence no further work up was done for these diseases. Thyroid disorders are frequent in SLE and are multifactorial with a definite higher prevalence of hypothyroidism as well as thyroid autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658291     DOI: 10.1007/s00296-010-1556-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

Review 1.  Chronic autoimmune thyroiditis and rheumatic manifestations.

Authors:  Leonardo Punzi; Corrado Betterle
Journal:  Joint Bone Spine       Date:  2004-07       Impact factor: 4.929

2.  Thyroid stimulating and thyrotrophin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalities.

Authors:  J R Baker; F W Miller; A D Steinberg; K D Burman
Journal:  Thyroid       Date:  1991       Impact factor: 6.568

3.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

4.  Effects of chronic renal disease on thyroid hormone metabolism.

Authors:  J F Finucane; R S Griffiths; E G Black; C L Hall
Journal:  Acta Endocrinol (Copenh)       Date:  1977-04

5.  Thyroid disorders in systemic lupus erythematosus.

Authors:  K L Goh; F Wang
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

6.  Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.

Authors:  A Burger; D Dinichert; P Nicod; M Jenny; T Lemarchand-Béraud; M B Vallotton
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

7.  Changes in thyroid hormone parameters after acute myocardial infarction.

Authors:  B Eber; M Schumacher; W Langsteger; R Zweiker; F M Fruhwald; R Pokan; R Gasser; O Eber; W Klein
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

8.  Thyroid disorders in Chinese patients with systemic lupus erythematosus.

Authors:  R T Tsai; T C Chang; C R Wang; C Y Chuang; C Y Chen
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

9.  Thyroid disorders in Korean patients with systemic lupus erythematosus.

Authors:  D J Park; C S Cho; S H Lee; S H Park; H Y Kim
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

10.  Autoimmune thyroid disease in primary Sjögren's syndrome.

Authors:  B Pérez; A Kraus; G López; M Cifuentes; D Alarcón-Segovia
Journal:  Am J Med       Date:  1995-11       Impact factor: 4.965

View more
  18 in total

Review 1.  Urticaria and autoimmunity: where are we now?

Authors:  Jenny M Stitt; Stephen C Dreskin
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

2.  Subclinical hypothyroidism is a risk factor for delayed clinical complete response in patients with systemic lupus erythematosus (SLE).

Authors:  Lin Dong; Liu Jia; Xuezhi Hong; Guangliang Chen; Hanyou Mo
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  SLE or hypothyroidism: who can triumph in cardiac tamponade?

Authors:  Sameer Sadashiv Chaudhari; Kashmira Pramod Wankhedkar; Savi Mushiyev
Journal:  BMJ Case Rep       Date:  2015-03-06

4.  Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus.

Authors:  Li Lu; Wei Kong; Kangxing Zhou; Jinglei Chen; Yayi Hou; Huan Dou; Jun Liang
Journal:  BMC Rheumatol       Date:  2021-06-09

5.  Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjögren's syndrome patients.

Authors:  Arkadiusz Koszarny; Maria Majdan; Magdalena Dryglewska; Jacek Tabarkiewicz
Journal:  Reumatologia       Date:  2015-05-18

6.  The Prevalence of Thyroid Dysfunction in Patients With Systemic Lupus Erythematosus.

Authors:  Nakisa Rasaei; Mesbah Shams; Eskandar Kamali-Sarvestani; Mohammad Ali Nazarinia
Journal:  Iran Red Crescent Med J       Date:  2015-12-05       Impact factor: 0.611

7.  Prevalence of systemic lupus erythematosus among patients of hypothyroidism in a tertiary care center.

Authors:  Rudrajit Paul; Pradip Raychaudhuri; Pradip Kumar Sinha; Sekhar Mookerjee; Kaushik Pandit; Gouranga Santra
Journal:  Indian J Endocrinol Metab       Date:  2012-07

Review 8.  Interaction of the endocrine system with inflammation: a function of energy and volume regulation.

Authors:  Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2014-02-13       Impact factor: 5.156

9.  Patterns of ambulatory medical care utilization and rheumatologist consultation predating the diagnosis of systemic lupus erythematosus: a national population-based study.

Authors:  Ning-Sheng Lai; Tzung-Yi Tsai; Malcolm Koo; Kuang-Yung Huang; Chien-Hsueh Tung; Ming-Chi Lu
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  Histological and ultrastructural alterations of rat thyroid gland after short-term treatment with high doses of thyroid hormones.

Authors:  Njia M Ali Rajab; Mirela Ukropina; Maja Cakic-Milosevic
Journal:  Saudi J Biol Sci       Date:  2015-05-13       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.